Ahrens Investment Partners’s Gilead Sciences GILD Stock Holding History

Ahrens Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$41.5K	Buy	+500	New	+$41.4K	0.02%	356
2022 Q3	–	Sell	-550	Closed	-$34K	–	454
2022 Q2	$34K	Sell	550 -156	-22%	-$9.66K	0.02%	398
2022 Q1	$42K	Sell	706 -555	-44%	-$35.5K	0.01%	424
2021 Q4	$92K	Buy	+1,261	New	+$86.9K	0.04%	295
2020 Q2	–	Sell	-2,888	Closed	-$216K	–	170
2020 Q1	$216K	Buy	+2,888	New	+$200K	0.16%	106
2017 Q1	–	Sell	-3,956	Closed	-$283K	–	160
2016 Q4	$283K	Buy	+3,956	New	+$294K	0.15%	96

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ahrens Investment Partners's GILD Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Gilead Sciences (GILD) in Q1 2023: 500 shares worth $41.5K. The stake represents 0.02% of the portfolio and ranks #356 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in GILD as recently as Q2 2022.

Ahrens Investment Partners first reported a position in GILD in Q4 2016 and has held it in 6 quarters since. The position peaked at $283K in Q4 2016. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Ahrens Investment Partners held 500 shares of Gilead Sciences worth $41.5K as of Q1 2023.
Gilead Sciences was a new Ahrens Investment Partners position in Q1 2023.
Gilead Sciences made up 0.02% of Ahrens Investment Partners's portfolio in Q1 2023, its #356 holding.
Ahrens Investment Partners first reported a position in Gilead Sciences in Q4 2016 and has held it in 6 quarters since.
Ahrens Investment Partners's Gilead Sciences position peaked at $283K in Q4 2016.
1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.